Epidemiologist
US FDA
Silver Spring, United States
Joann F. Gruber has a PhD in epidemiology. She works as an epidemiologist at the U.S. Food and Drug Administration in the Center for Biologics Evaluation and Research in the Office of Biostatistics and Pharmacovigilance. She is a member of the CBER Surveillance Program. The CBER Surveillance Program conducts post-marketing safety surveillance of CBER-regulated products, including vaccines, to inform regulatory decisions.
Disclosure information not submitted.
Monday, August 26, 2024
2:30 PM – 2:45 PM CEST
Tuesday, August 27, 2024
9:15 AM – 9:30 AM CEST
Tuesday, August 27, 2024
1:00 PM – 1:15 PM CEST
Risk of Neurologic or Immune-Mediated Adverse Events After COVID-19 Diagnosis in the United States
Wednesday, August 28, 2024
1:30 PM – 1:45 PM CEST
Risk of Cardiovascular Adverse Events After COVID-19 Diagnosis in the United States
Wednesday, August 28, 2024
2:45 PM – 3:00 PM CEST